Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -30.00 (-2.38%)
Bid:
1,232.00
Ask:
1,246.00
Spread: 14.00 (1.136%)
Market Cap: £239.12m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Transaction in Own Shares

19 Dec 2025 17:27

For immediate re lease

19 December 2025

THE BIOTECH GROWTH TRUST PLC

(the "Company")

MARKET PURCHASE OF COMPANY'S OWN SHARES

 

 

 

Notification is given, pursuant to the authority granted at the General Meeting of the Company held on 12 November 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 3,291,239 that a market total of 26,428 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 1212.97 pence per share.

 

Following this transaction, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company 21,125,520. The Company does not currently hold any Ordinary shares in treasury.

 

The figure of 21,125,520 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

 

Katherine Manson

Frostrow Capital LLP

Tel: 020 3709 8734



Date   Source Headline
10th Apr 20265:23 pmPRNTransaction in Own Shares
10th Apr 20262:36 pmPRNNet Asset Value(s)
9th Apr 20261:22 pmPRNNet Asset Value(s)
8th Apr 20263:05 pmPRNNet Asset Value(s)
7th Apr 20261:08 pmPRNNet Asset Value(s)
2nd Apr 20265:01 pmPRNTransaction in Own Shares
2nd Apr 20262:23 pmPRNNet Asset Value(s)
1st Apr 20264:16 pmPRNNet Asset Value(s)
1st Apr 20269:59 amPRNTotal Voting Rights
1st Apr 20267:00 amPRNBiogen, Inc. to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc.
31st Mar 202612:42 pmPRNNet Asset Value(s)
30th Mar 202612:43 pmPRNNet Asset Value(s)
27th Mar 20265:16 pmPRNTransaction in Own Shares
27th Mar 20261:35 pmPRNNet Asset Value(s)
26th Mar 20261:08 pmPRNNet Asset Value(s)
25th Mar 20262:08 pmPRNNet Asset Value(s)
24th Mar 202612:34 pmPRNNet Asset Value(s)
23rd Mar 20263:13 pmPRNNet Asset Value(s)
20th Mar 20265:18 pmPRNTransaction in Own Shares
20th Mar 20261:55 pmPRNNet Asset Value(s)
19th Mar 202612:38 pmPRNNet Asset Value(s)
18th Mar 20261:35 pmPRNNet Asset Value(s)
17th Mar 202612:41 pmPRNNet Asset Value(s)
16th Mar 20262:15 pmPRNNet Asset Value(s)
13th Mar 20265:19 pmRNSTransaction in Own Shares
13th Mar 20265:19 pmPRNTransaction in Own Shares
13th Mar 20262:54 pmPRNNet Asset Value(s)
12th Mar 20261:16 pmPRNNet Asset Value(s)
12th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
11th Mar 20262:08 pmRNSMonthly Fact Sheet as at 28 February 2026
11th Mar 20262:08 pmPRNMonthly Fact Sheet as at 28 February 2026
11th Mar 20261:00 pmPRNNet Asset Value(s)
10th Mar 20261:28 pmPRNNet Asset Value(s)
9th Mar 20261:49 pmPRNNet Asset Value(s)
6th Mar 20265:12 pmPRNTransaction in Own Shares
6th Mar 20261:21 pmPRNNet Asset Value(s)
5th Mar 202612:16 pmPRNNet Asset Value(s)
4th Mar 20261:17 pmPRNNet Asset Value(s)
3rd Mar 20261:01 pmPRNNet Asset Value(s)
2nd Mar 20261:17 pmPRNNet Asset Value(s)
2nd Mar 202610:11 amPRNTotal Voting Rights
2nd Mar 20267:00 amPRNInvestor Webinar
27th Feb 20265:43 pmPRNTransaction in Own Shares
27th Feb 20262:10 pmPRNNet Asset Value(s)
26th Feb 20261:58 pmPRNNet Asset Value(s)
25th Feb 20262:31 pmPRNNet Asset Value(s)
24th Feb 202612:23 pmPRNNet Asset Value(s)
23rd Feb 20261:45 pmPRNNet Asset Value(s)
20th Feb 20265:21 pmPRNTransaction in Own Shares
20th Feb 20261:35 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.